AroCell – AROC
|Short name (ticker) at Nasdaq Stockholm||AROC|
The shares are registered by Euroclear Sweden AB.
AroCell shares have been traded since 30 June 2016 on Nasdaq First North Growth Market Sweden.
The company has 230,361,066 shares and the shares’ quota value is SEK 0.10 per share.
For more information about AroCell on Nasdaq First North Growth Market.
We provide knowledge to decision.
AroCell is a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.
An effective typhoid test
Typhoid fever is water and food-borne infectious disease caused by the bacterium, Salmonella enterica. IDL Biotechs product TUBEX® TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.
Diagnostics for oncology
Cancer is one of the leading causes of death worldwide, despite advancing knowledge. To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.